Yong Liu

Yong Liu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Trends in Cancer
Verified
Journal Article
Closed access
YLYong Liu
Yong Liu
PLPatrick L. Leslie
Patrick L. Leslie
YZYanping Zhang
Yanping Zhang

6 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HCHao Cui
Hao Cui
HSHongjian Shan
Hongjian Shan
MMMichael Zhe Miao
Michael Zhe Miao
ZJZhiguo Jiang
Zhiguo Jiang
YMYuanyuan Meng
Yuanyuan Meng
YLYong Liu
Yong Liu
Kidney renal clear cell carcinoma (KIRC) is the most common renal cell carcinoma (RCC). However, patients with KIRC usually have poor prognosis due to limited biomarkers for early detection and prognosis prediction. In this study, we analysed key genes and pathways involved in KIRC from an array dataset including 26 tumour and 26 adjacent normal tissue samples. Weighted gene co-expression network analysis (WGCNA) was performed with the WGCNA package, and 20 modules were characterized as having the highest correlation with KIRC. The upregulated genes in the tumour samples are involved in the innate immune response, whereas the downregulated genes contribute to the cellular catabolism of glucose, amino acids and fatty acids. Furthermore, the key genes were evaluated through a protein-protein interaction (PPI) network combined with a co-expression network. The comparatively lower expression of AGXT, PTGER3 and SLC12A3 in tumours correlates with worse prognosis in KIRC patients, while higher expression of ALOX5 predicts reduced survival. Our integrated analysis illustrated the hub genes involved in KIRC tumorigenesis, shedding light on the development of prognostic markers. Further understanding of the function of the identified KIRC hub genes could provide deep insights into the molecular mechanisms of KIRC.

13 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPeng Shi
Peng Shi
XRXiaoyu Ren
Xiaoyu Ren
JMJie Meng
Jie Meng
CKChenlu Kang
Chenlu Kang
YWYihe Wu
Yihe Wu
CWCongying Wu
Congying Wu
The folded mitochondria inner membrane-cristae is the structural foundation for oxidative phosphorylation (OXPHOS) and energy production. By mechanically simulating mitochondria morphogenesis, we speculate that efficient sculpting of the cristae is organelle non-autonomous. It has long been inferred that folding requires buckling in living systems. However, the tethering force for cristae formation and regulation has not been identified. Combining electron tomography, proteomics strategies, super resolution live cell imaging and mathematical modeling, we reveal that the mitochondria localized actin motor-myosin 19 (Myo19) is critical for maintaining cristae structure, by associating with the SAM-MICOS super complex. We discover that depletion of Myo19 or disruption of its motor activity leads to altered mitochondria membrane potential and decreased OXPHOS. We propose that Myo19 may act as a mechanical tether for effective ridging of the mitochondria cristae, thus sustaining the energy homeostasis essential for various cellular functions.

7 September 2022 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
BWBingwu Wang
Bingwu Wang
JGJian Gao
Jian Gao
ZZZhongjun Zhao
Zhongjun Zhao
XZXuefei Zhong
Xuefei Zhong
HCHao Cui
Hao Cui
YLYong Liu
Yong Liu
Background: Targeting ribosome biogenesis to activate p53 has recently emerged as a therapeutic strategy in human cancer. Among various ribosomal proteins, RPL11 centralizes the nucleolar stress-sensing pathway by binding MDM2, leading to MDM2 inactivation and p53 activation. Therefore, the identification of MDM2-binding RPL11-mimetics would be valuable for anti-cancer therapeutics. Methods: Based on the crystal structure of the interface between RPL11 and MDM2, we have identified 15 potential allosteric modulators of MDM2 through the virtual screening. Results: One of these compounds, named S9, directly binds MDM2 and competitively inhibits the interaction between RPL11 and MDM2, leading to p53 stabilization and activation. Moreover, S9 inhibits cancer cell proliferation in vitro and in vivo. Mechanistic study reveals that MDM2 is required for S9-induced G2 cell cycle arrest and apoptosis, whereas p53 contributes to S9-induced apoptosis. Conclusions: Putting together, S9 may serve as a lead compound for the development of an anticancer drug that specifically targets RPL11-MDM2-p53 pathway.

2 December 2023 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HCHao Cui
Hao Cui
BZBao Zhu
Bao Zhu
HLHuiyan Li
Huiyan Li
YMYuanyuan Meng
Yuanyuan Meng
MCMeng Cai
Meng Cai
YLYong Liu
Yong Liu

19 September 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
LSLiang Sun
Liang Sun
HMHanjing Meng
Hanjing Meng
TLTao Liu
Tao Liu
QZQiong Zhao
Qiong Zhao
MXMingyi Xia
Mingyi Xia
YLYong Liu
Yong Liu
Cancer cells undergo metabolic reprogramming that is intricately linked to malignancy. Protein acylations are especially responsive to metabolic changes, influencing signal transduction pathways and fostering cell proliferation. However, as a novel type of acylations, the involvement of malonylation in cancer remains poorly understood. In this study, we observed a significant reduction in malonyl-CoA levels in hepatocellular carcinoma (HCC), which correlated with a global decrease in malonylation. Subsequent nuclear malonylome analysis unveiled nucleolin (NCL) malonylation, which was notably enhanced in HCC biopsies. we demonstrated that NCL undergoes malonylation at lysine residues 124 and 398. This modification triggers the translocation of NCL from the nucleolus to nucleoplasm and cytoplasm, binding to AKT mRNA, and promoting AKT translation in HCC. Silencing AKT expression markedly attenuated HCC cell proliferation driven by NCL malonylation. These findings collectively highlight nuclear signaling in modulating AKT expression, suggesting NCL malonylation as a novel mechanism through which cancer cells drive cell proliferation.